We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




First Digital Pathology Solution Receives FDA Clearance

By MedImaging International staff writers
Posted on 25 Apr 2017
Print article
Image: A pathologist using the new digital pathology solution (Photo courtesy of Royal Philips).
Image: A pathologist using the new digital pathology solution (Photo courtesy of Royal Philips).
After evaluating data from a clinical study including around 2,000 surgical pathology cases, the US FDA has cleared the first digital pathology solution for primary diagnostic use in the U.S.

Digital pathology can help pathologists view and diagnose digital images of surgical pathology slides, streamline workflows in pathology departments, and increase collaboration and diagnostic confidence.

The US Food and Drug Administration (FDA) approval will now enable Royal Philips to market its IntelliSite Pathology Solution for the digital pathology lab.

As cancer cases increase, pathology services need to deal with an increasing number and complexity of tests for cancer care. Digital pathology has already helped increase efficiency in the primary diagnosis of histopathology images outside the U.S. since 2014.

The Philips IntelliSite Pathology solution automates the creation, viewing and management of digital pathology images and includes advanced software tools that help manage information sharing, and other services. Digital pathology can also use computational pathology tools that provide more accurate image analysis, and predictive health management.

General Manager of Philips Digital Pathology Solutions, Russ Granzow, said, “Not only will it promote increased efficiencies and collaboration between pathologists, but it also opens a complete new dimension towards computational pathology which aims to increase accuracies and ultimately enhance patient care. The clearance for Philips IntelliSite Pathology Solution marks a major milestone for innovation in pathology services in the U.S.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Ultrasound Table
Ergonomic Advantage (EA) Line
Under Table Shield
3 Section Double Pivot Under Table Shield

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.